Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2013
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and AztreonamMichael N Dudley, Paul G Ambrose, Sujata M Bhavnani, et al.
The Pediatric Infectious Disease Journal|July 23, 2008
Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonateJohn S Bradley, Jason B Sauberan, Paul G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection ModelB D VanScoy, S Jones, H Conde, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation SolutionElizabeth A Lakota, Nobuo Sato, Tomokazu Koresawa, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumoniaChristopher M Rubino, Alan Forrest, Sujata M Bhavnani, et al.
Open Forum Infectious Diseases|December 25, 2018
Time for Precision: A World Without Susceptibility BreakpointsJustin C Bader, Elizabeth A Lakota, David R Andes, et al.
Clinical and Experimental Immunology|July 1, 1995
Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodiesS J Bowman, M Bhavnani, G C Geddes, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapyJ K Thomas, A Forrest, S M Bhavnani, et al.
Arthritis and Rheumatism|January 1, 1995
Mannose-binding protein gene polymorphism in systemic lupus erythematosusE J Davies, N Snowden, M C Hillarby, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body SizesElizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Pageof 21